Jump to Content
Jump to Main Navigation
HOME
BROWSE
SUBJECTS
CLINICAL RESOURCES
DRUG INFORMATION
EDUCATION AND TRAINING
PHARMACY PRACTICE
CAREER DEVELOPMENT
AJHP
DRUG INFORMATION
PROFESSIONAL DEVELOPMENT
Sign in
Sign up
SEARCH
Advanced Search
Help
Sign in
Sign up
HOME
BROWSE
SUBJECTS
CLINICAL RESOURCES
DRUG INFORMATION
EDUCATION AND TRAINING
PHARMACY PRACTICE
CAREER DEVELOPMENT
AJHP
DRUG INFORMATION
PROFESSIONAL DEVELOPMENT
SEARCH
Advanced Search
Help
Search within results
Search within results
Filter
Filter
Refine by Subjects
Clinical Resources
(1,314)
Drug Information
(932)
Educational & Training
(244)
Pharmacy Practice
(19)
Refine by Access
All content
Content accessible to me
Refine by Type
Books
(20)
Chapters
(1,294)
Submit
Refine by Date
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2009
2008
2002
—
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2009
2008
2002
Submit
Print
Save
Email this link
Share Link
Copy this link, or click below to email it to a friend
Email this link
or copy the link directly:
https://publications.ashp.org/collection/ClinicalResources?access=all&page=9&pageSize=50&sort=datedescending
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully
Copy link
Browse
You are looking at
401
-
450
of
1,314
items for
Refine by Access: All content
x
Clear All
Items per page:
10
20
50
Sort by:
Title A - Z
Title Z - A
Author A - Z
Author Z - A
Date - Old to Recent
Date - Recent to Old
Page: ...
4
5
6
7
8
9
10
11
12
13
14
...
Restricted access
Levodopa 5 mg/mL and Carbidopa 1.25 mg/mL Suspension—Formulation 2
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Levofloxacin Suspension 50 mg/mL—Formulation 1
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Levofloxacin Suspension 50 mg/mL—Formulation 2
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Levothyroxine Sodium Solution 25 mcg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
16 LIDOCAINE
Toby C. Trujillo
Chapter
In
Clinical Pharmacokinetics
Published (Print):
01 Jan 2022
Restricted access
8 Lipid Disorders
Jill S. Borchert and Kathy E. Komperda
Chapter
In
Basic Skills in Interpreting Laboratory Data
Published (Print):
01 Jan 2022
Restricted access
Lisinopril Suspension 1 mg/mL—Formulation 1
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Lisinopril Suspension 1 mg/mL—Formulation 2
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Lisinopril Syrup 1 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Lisinopril Syrup 2 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
CH 2.9 Lithium
John E. Murphy
Chapter
In
Clinical Pharmacokinetics Workbook
Published (Print):
01 Jan 2022
Restricted access
CH 1.9 Lithium
John E. Murphy
Chapter
In
Clinical Pharmacokinetics Workbook
Published (Print):
01 Jan 2022
Restricted access
17 LITHIUM
Tanya J. Fabian and Matthew A. Fuller
Chapter
In
Clinical Pharmacokinetics
Published (Print):
01 Jan 2022
Restricted access
15 Liver and Gastroenterology Tests
Paul Farkas, Joanna Sampson, Matthew Slitzky, and Jason Altman
Chapter
In
Basic Skills in Interpreting Laboratory Data
Published (Print):
01 Jan 2022
Restricted access
Lorazepam Suspension 1 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Losartan Suspension 2.5 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
CH 2.2 Medication Dosing in Overweight and Obese Patients
John E. Murphy
Chapter
In
Clinical Pharmacokinetics Workbook
Published (Print):
01 Jan 2022
Restricted access
CH 1.2 Medication Dosing in Overweight and Obese Patients
John E. Murphy
Chapter
In
Clinical Pharmacokinetics Workbook
Published (Print):
01 Jan 2022
Restricted access
4 MEDICATION DOSING IN OVERWEIGHT AND OBESE PATIENTS
Brian L. Erstad
Chapter
In
Clinical Pharmacokinetics
Published (Print):
01 Jan 2022
Restricted access
Melatonin 1 mg/mL and Pyridoxine Hydrochloride 3.3 mg/mL Suspension
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Melatonin Suspension 1 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Melatonin Suspension 3 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
25 Men’s Health
Mary Lee and Roohollah Sharifi
Chapter
In
Basic Skills in Interpreting Laboratory Data
Published (Print):
01 Jan 2022
Restricted access
Mercaptopurine Suspension 10 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Mercaptopurine Syrup 50 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Methadone Hydrochloride Suspension 10 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Methotrexate Syrup 2 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Methylcellulose Suspension 10 mg/mL (1%)
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Methyldopa Syrup 50 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Metolazone Suspension 1 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Metoprolol Tartrate Suspension 10 mg/mL—Formulation 1*
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Metoprolol Tartrate Suspension 10 mg/mL—Formulation 2
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Metronidazole Suspension 10 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Metronidazole Suspension 50 mg/mL*
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Metronidazole Syrup 5 mg/mL—Formulation 1
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Metronidazole Syrup 5 mg/mL—Formulation 2
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Mexiletine Solution 10 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Midazolam Hydrochloride Gelatin 1 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Midazolam Hydrochloride Gelatin 2 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Midazolam Hydrochloride Suspension 1 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Midazolam Hydrochloride Syrup 2.5 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Minocycline Hydrochloride Suspension 10 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Minoxidil Suspension 1 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Morphine Hydrochloride Solution 1 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Morphine Sulfate Solution 0.4 mg/mL*
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Moxifloxacin Suspension 20 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Mycophenolate Mofetil Suspension 50 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Mycophenolate Mofetil Syrup 100 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Naproxen Suspension 25 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Naratriptan Hydrochloride Suspension 0.5 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Items per page:
10
20
50
Sort by:
Title A - Z
Title Z - A
Author A - Z
Author Z - A
Date - Old to Recent
Date - Recent to Old
Page: ...
4
5
6
7
8
9
10
11
12
13
14
...
[3.236.207.90]
3.236.207.90
